|
US4173691A
(en)
|
1978-02-21 |
1979-11-06 |
M&T Chemicals Inc. |
Catalyst composition for flexible polyurethane foams
|
|
US4182827A
(en)
*
|
1978-08-31 |
1980-01-08 |
Union Carbide Corporation |
Polyurethane hydrogels having enhanced wetting rates
|
|
US4568737A
(en)
|
1983-01-07 |
1986-02-04 |
The Dow Chemical Company |
Dense star polymers and dendrimers
|
|
US4558120A
(en)
|
1983-01-07 |
1985-12-10 |
The Dow Chemical Company |
Dense star polymer
|
|
US4737550A
(en)
|
1983-01-07 |
1988-04-12 |
The Dow Chemical Company |
Bridged dense star polymers
|
|
US4631337A
(en)
|
1983-01-07 |
1986-12-23 |
The Dow Chemical Company |
Hydrolytically-stable dense star polyamine
|
|
US4507466A
(en)
|
1983-01-07 |
1985-03-26 |
The Dow Chemical Corporation |
Dense star polymers having core, core branches, terminal groups
|
|
US4600001A
(en)
*
|
1984-08-15 |
1986-07-15 |
The Kendall Company |
Combined wound dressing and delivery means composite
|
|
US4587329A
(en)
|
1984-08-17 |
1986-05-06 |
The Dow Chemical Company |
Dense star polymers having two dimensional molecular diameter
|
|
US4550126A
(en)
*
|
1985-01-25 |
1985-10-29 |
Hydromer, Inc. |
Hydrophilic, flexible, open cell polyurethane-poly(N-vinyl lactam) interpolymer foam and dental and biomedical products fabricated therefrom
|
|
US4871779A
(en)
|
1985-12-23 |
1989-10-03 |
The Dow Chemical Company |
Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities
|
|
US4694064A
(en)
|
1986-02-28 |
1987-09-15 |
The Dow Chemical Company |
Rod-shaped dendrimer
|
|
US4713975A
(en)
|
1986-05-30 |
1987-12-22 |
The Dow Chemical Company |
Dense star polymers for calibrating/characterizing sub-micron apertures
|
|
US4857599A
(en)
|
1988-02-08 |
1989-08-15 |
The Dow Chemical Company |
Modified dense star polymers
|
|
US5061487A
(en)
|
1988-05-09 |
1991-10-29 |
Dow Corning Corporation |
Antimicrobial superabsorbent compositions and methods
|
|
US5045322A
(en)
|
1988-05-09 |
1991-09-03 |
Dow Corning Corporation |
Antimicrobial superabsorbent sanitary napkin
|
|
US5035892A
(en)
|
1988-05-09 |
1991-07-30 |
Dow Corning Corporation |
Antimicrobial superabsorbent compositions and methods
|
|
US4985023A
(en)
|
1988-05-09 |
1991-01-15 |
Dow Corning Corporation |
Antimicrobial superabsorbent articles
|
|
US4990338A
(en)
|
1988-05-09 |
1991-02-05 |
Dow Corning Corporation |
Antimicrobial superabsorbent compositions and methods
|
|
US5079004A
(en)
|
1990-08-06 |
1992-01-07 |
Dow Corning Corporation |
Antimicrobial superabsorbent compositions and method
|
|
GB9102660D0
(en)
*
|
1991-02-07 |
1991-03-27 |
Ultra Lab Ltd |
Wound dressing materials
|
|
US5380758A
(en)
|
1991-03-29 |
1995-01-10 |
Brigham And Women's Hospital |
S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
|
|
DK1023900T3
(da)
|
1991-11-14 |
2005-06-06 |
Brigham & Womens Hospital |
Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
|
|
US6291424B1
(en)
|
1991-11-14 |
2001-09-18 |
Brigham And Women's Hospital |
Nitrosated and nitrosylated heme proteins
|
|
US5194325A
(en)
|
1992-02-25 |
1993-03-16 |
Renosol Corporation |
Molded polyurethane foam system utilizing HFC blowing agents
|
|
SE9200564L
(sv)
|
1992-02-26 |
1993-03-15 |
Perstorp Ab |
Dendritisk makromolekyl av polyestertyp, foerfarande foer framstaellning daerav samt anvaendning daerav
|
|
US5814666A
(en)
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
|
US5691423A
(en)
|
1992-08-24 |
1997-11-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-bound nitric oxide-nucleophile adducts
|
|
US5650447A
(en)
|
1992-08-24 |
1997-07-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Nitric oxide-releasing polymers to treat restenosis and related disorders
|
|
US5910316A
(en)
|
1992-08-24 |
1999-06-08 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Use of nitric oxide-releasing agents to treat impotency
|
|
US5405919A
(en)
*
|
1992-08-24 |
1995-04-11 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
|
|
US5632981A
(en)
|
1992-08-24 |
1997-05-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
US6200558B1
(en)
|
1993-09-14 |
2001-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
US5525357A
(en)
|
1992-08-24 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
US5852058A
(en)
|
1993-06-11 |
1998-12-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
|
|
US5891459A
(en)
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
|
US5428070A
(en)
|
1993-06-11 |
1995-06-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
|
|
US5861168A
(en)
|
1993-06-11 |
1999-01-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
|
|
EP1393723A3
(en)
|
1993-09-17 |
2004-10-20 |
The Brigham And Women's Hospital, Inc. |
Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
|
|
US6087479A
(en)
|
1993-09-17 |
2000-07-11 |
Nitromed, Inc. |
Localized use of nitric oxide-adducts to prevent internal tissue damage
|
|
US6255277B1
(en)
|
1993-09-17 |
2001-07-03 |
Brigham And Women's Hospital |
Localized use of nitric oxide-adducts to prevent internal tissue damage
|
|
EP0722320B1
(en)
|
1993-10-08 |
2000-07-19 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Use of nitric oxide-releasing compounds as medicaments for hypoxic cell radiation sensitization
|
|
US5840759A
(en)
|
1993-10-08 |
1998-11-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
|
|
WO1995012394A1
(en)
|
1993-11-02 |
1995-05-11 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
|
|
US5786332A
(en)
|
1995-03-06 |
1998-07-28 |
Trega Biosciences, Inc. |
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
|
|
US5726156A
(en)
|
1995-03-06 |
1998-03-10 |
Trega Biosciences, Inc. |
Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
|
|
US5599984A
(en)
|
1994-01-21 |
1997-02-04 |
The Picower Institute For Medical Research |
Guanylhydrazones and their use to treat inflammatory conditions
|
|
US6008255A
(en)
|
1994-01-21 |
1999-12-28 |
The Picower Institute For Medical Research |
Guanylhydrazones and their use to treat inflammatory conditions
|
|
ATE264685T1
(de)
|
1994-02-21 |
2004-05-15 |
Univ Aberdeen |
Angesäuertes nitrit zur verwendung als antimikrobielles mittel
|
|
US6709681B2
(en)
|
1995-02-17 |
2004-03-23 |
Aberdeen University |
Acidified nitrite as an antimicrobial agent
|
|
US5504117A
(en)
|
1994-05-27 |
1996-04-02 |
Neptune Pharmaceutical Corporation |
Pharmacologic preparation for the treatment of anal disorders
|
|
DE69518729T2
(de)
|
1994-05-27 |
2001-05-31 |
Cellegy Pharmaceuticals, Inc. |
Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
|
|
US6190704B1
(en)
|
1994-09-23 |
2001-02-20 |
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Regulation of wound healing by nitric oxide
|
|
US6747062B2
(en)
|
1994-09-26 |
2004-06-08 |
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Regulation of wound healing by nitric oxide
|
|
US5519020A
(en)
|
1994-10-28 |
1996-05-21 |
The University Of Akron |
Polymeric wound healing accelerators
|
|
US5629322A
(en)
|
1994-11-15 |
1997-05-13 |
Merck & Co., Inc. |
Cyclic amidine analogs as inhibitors of nitric oxide synthase
|
|
US5700830A
(en)
|
1994-11-22 |
1997-12-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of nitric oxide-releasing agents for reducing metastasis risk
|
|
US5999843A
(en)
|
1995-01-03 |
1999-12-07 |
Omnicorder Technologies, Inc. |
Detection of cancerous lesions by their effect on the spatial homogeneity of skin temperature
|
|
US5810010A
(en)
|
1995-01-03 |
1998-09-22 |
Anbar; Michael |
Detection of cancerous lesions by their effect on the periodic modulation of perfusion in the surrounding tissues
|
|
US6035225A
(en)
|
1995-01-03 |
2000-03-07 |
Omnicorder Technologies |
Detection of cancerous lesions by measuring nitric oxide concentrations in tissue
|
|
US5961466A
(en)
|
1995-01-03 |
1999-10-05 |
Omnicorder Technologies, Inc. |
Method of detection of cancerous lesions by their effect on the spatial distribution of modulation of temperature and homogeneity of tissue
|
|
CA2207961A1
(en)
|
1995-01-05 |
1996-07-11 |
Robert J. Levy |
Surface-modified nanoparticles and method of making and using same
|
|
US5665077A
(en)
|
1995-04-24 |
1997-09-09 |
Nitrosci Pharmaceuticals Llc |
Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
|
|
US5623981A
(en)
|
1995-08-17 |
1997-04-29 |
Service Station Products Company |
Safety barrier for rim holding tire changers
|
|
US6043358A
(en)
|
1995-11-01 |
2000-03-28 |
Merck & Co., Inc. |
Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
|
|
DE69637676D1
(de)
|
1995-11-09 |
2008-10-23 |
Univ R |
Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
|
|
US5821261A
(en)
|
1995-12-08 |
1998-10-13 |
Merck & Co., Inc. |
Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
|
|
US20020143007A1
(en)
|
1996-02-02 |
2002-10-03 |
Garvey David S. |
Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
|
|
US5932538A
(en)
|
1996-02-02 |
1999-08-03 |
Nitromed, Inc. |
Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
|
|
US5994294A
(en)
|
1996-02-02 |
1999-11-30 |
Nitromed, Inc. |
Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
|
|
US6323211B1
(en)
|
1996-02-02 |
2001-11-27 |
Nitromed, Inc. |
Compositions and methods for treating sexual dysfunctions
|
|
US20020061879A1
(en)
|
1996-02-02 |
2002-05-23 |
Garvey David S. |
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
|
|
US6294517B1
(en)
|
1996-02-02 |
2001-09-25 |
Nitromed, Inc. |
Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
|
|
US6469065B1
(en)
|
1996-02-02 |
2002-10-22 |
Nitromed, Inc. |
Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
|
|
US20050065161A1
(en)
|
1996-02-02 |
2005-03-24 |
Nitromed, Inc. |
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
|
|
IT1282686B1
(it)
|
1996-02-26 |
1998-03-31 |
Nicox Sa |
Composti in grado di ridurre la tossicita' da farmaci
|
|
EP0907747A1
(en)
|
1996-03-15 |
1999-04-14 |
Yale University |
Methods and means of detecting nitric oxide synthase
|
|
US5968001A
(en)
|
1996-05-14 |
1999-10-19 |
Bristol-Myers Squibb Company |
Wound dressings with leak prevention seal
|
|
US6143037A
(en)
|
1996-06-12 |
2000-11-07 |
The Regents Of The University Of Michigan |
Compositions and methods for coating medical devices
|
|
US5789451A
(en)
|
1996-07-29 |
1998-08-04 |
The Dow Chemcial Company |
Alkanolamine/carbon dioxide adduct and polyurethane foam therewith
|
|
US5770645A
(en)
|
1996-08-02 |
1998-06-23 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
|
US6232434B1
(en)
|
1996-08-02 |
2001-05-15 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
|
US5797887A
(en)
|
1996-08-27 |
1998-08-25 |
Novovasc Llc |
Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
|
|
WO1998008496A1
(en)
|
1996-08-27 |
1998-03-05 |
The University Of Akron |
Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
|
|
US20030093143A1
(en)
|
1999-03-01 |
2003-05-15 |
Yiju Zhao |
Medical device having surface depressions containing nitric oxide releasing compound
|
|
EP2292630B1
(en)
|
1996-09-27 |
2015-11-25 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
|
|
GB9622997D0
(en)
|
1996-11-05 |
1997-01-08 |
Univ St Andrews |
Nitric oxide donor drugs
|
|
US5958427A
(en)
|
1996-11-08 |
1999-09-28 |
Salzman; Andrew L. |
Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
|
|
US6372796B1
(en)
|
1996-11-13 |
2002-04-16 |
Cold Spring Harbor Laboratory |
Therapeutic uses for nitric oxide inhibitors
|
|
US5891472A
(en)
|
1996-11-19 |
1999-04-06 |
Meri Charmyne Russell |
Treatment of equine laminitis
|
|
WO1998029101A1
(en)
|
1996-12-31 |
1998-07-09 |
Antioxidant Pharmaceuticals Corporation |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
US6896899B2
(en)
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
ES2210716T3
(es)
|
1997-01-17 |
2004-07-01 |
Cascade Engineering, Inc. |
Panel con puerta integralmente moldeada.
|
|
WO1998033379A1
(en)
|
1997-02-04 |
1998-08-06 |
The General Hospital Corporation |
A novel method for treating epidermal or dermal conditions
|
|
US6034752A
(en)
|
1997-03-22 |
2000-03-07 |
Kent Displays Incorporated |
Display device reflecting visible and infrared radiation
|
|
IL120531A
(en)
|
1997-03-26 |
2006-12-31 |
Yissum Res Dev Co |
Nitric oxide donors and pharmaceutical compositions containing them
|
|
US5968528A
(en)
|
1997-05-23 |
1999-10-19 |
The Procter & Gamble Company |
Skin care compositions
|
|
US6171232B1
(en)
|
1997-06-26 |
2001-01-09 |
Cordis Corporation |
Method for targeting in vivo nitric oxide release
|
|
US6232336B1
(en)
|
1997-07-03 |
2001-05-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
|
|
US6796966B2
(en)
|
1997-10-15 |
2004-09-28 |
Jeffrey E. Thomas |
Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
|
|
CA2306096A1
(en)
|
1997-10-15 |
1999-04-22 |
Thomas Jefferson University |
Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
|
|
US5994444A
(en)
|
1997-10-16 |
1999-11-30 |
Medtronic, Inc. |
Polymeric material that releases nitric oxide
|
|
US20020013304A1
(en)
|
1997-10-28 |
2002-01-31 |
Wilson Leland F. |
As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
|
|
CA2219867A1
(en)
|
1997-10-31 |
1999-04-30 |
Jiangping Wu |
The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
|
|
US6180082B1
(en)
|
1997-11-24 |
2001-01-30 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Method to enhance tissue accumulation of radiolabeled compounds
|
|
ATE277038T1
(de)
|
1997-12-23 |
2004-10-15 |
Amersham Health As |
Stickstoffoxid freisetzende chelatbildner und ihre therapeutische verwendung
|
|
GB9801398D0
(en)
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
IT1298338B1
(it)
|
1998-03-05 |
1999-12-20 |
Nicox Sa |
Composizioni farmaceutiche per l'ulcera
|
|
US6560478B1
(en)
|
1998-03-16 |
2003-05-06 |
The Research Foundation Of City University Of New York |
Method and system for examining biological materials using low power CW excitation Raman spectroscopy
|
|
US6151522A
(en)
|
1998-03-16 |
2000-11-21 |
The Research Foundation Of Cuny |
Method and system for examining biological materials using low power CW excitation raman spectroscopy
|
|
US5962520A
(en)
|
1998-04-02 |
1999-10-05 |
The University Of Akron |
Hydrolytically unstable, biocompatible polymer
|
|
US6103266A
(en)
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
|
US6103275A
(en)
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
|
US6207855B1
(en)
|
1998-06-23 |
2001-03-27 |
Duke University Medical Center |
Stable no-delivering compounds
|
|
US20020068365A1
(en)
|
1998-07-28 |
2002-06-06 |
Eric H. Kuhrts |
Controlled release nitric oxide producing agents
|
|
US20060240070A1
(en)
*
|
1998-09-24 |
2006-10-26 |
Cromack Keith R |
Delivery of highly lipophilic agents via medical devices
|
|
US20040043068A1
(en)
|
1998-09-29 |
2004-03-04 |
Eugene Tedeschi |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
|
US6299980B1
(en)
|
1998-09-29 |
2001-10-09 |
Medtronic Ave, Inc. |
One step lubricious coating
|
|
US6379691B1
(en)
|
1998-09-29 |
2002-04-30 |
Medtronic/Ave, Inc. |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
|
DE19852681A1
(de)
*
|
1998-11-16 |
2000-05-18 |
Basf Ag |
Carbamatlösungen
|
|
US20070086954A1
(en)
|
1998-11-23 |
2007-04-19 |
Miller Christopher C |
Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
|
|
CA2254645A1
(en)
|
1998-11-23 |
2000-05-23 |
Pulmonox Medical Corporation |
Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
|
|
US20070275100A1
(en)
|
1998-11-23 |
2007-11-29 |
Miller Christopher C |
Use of gaseous nitric oxide as an anti-cancer agent
|
|
US6261594B1
(en)
|
1998-11-25 |
2001-07-17 |
The University Of Akron |
Chitosan-based nitric oxide donor compositions
|
|
US6238683B1
(en)
|
1998-12-04 |
2001-05-29 |
Johnson & Johnson Consumer Companies, Inc. |
Anhydrous topical skin preparations
|
|
US7179475B1
(en)
|
1998-12-04 |
2007-02-20 |
Johnson & Johnson Consumer Companies, Inc. |
Anhydrous topical skin preparations
|
|
GB9905425D0
(en)
|
1999-03-09 |
1999-05-05 |
Queen Mary & Westfield College |
Pharmaceutical composition
|
|
US20050142218A1
(en)
|
2000-03-09 |
2005-06-30 |
Queen Mary & Westfield College |
Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia
|
|
US6312663B1
(en)
|
1999-03-19 |
2001-11-06 |
Joseph V. Boykin, Jr. |
Prediction of diabetes impaired wound healing by urinary nitrate assay
|
|
US6562785B1
(en)
|
1999-03-23 |
2003-05-13 |
Howard M. Shapiro |
Method for overcoming bacterial antibiotic resistance
|
|
WO2000067813A1
(en)
*
|
1999-05-07 |
2000-11-16 |
Salviac Limited |
Biostable polyurethane products
|
|
HUP0202150A3
(en)
|
1999-06-14 |
2003-10-28 |
Henry Ford Health System Detro |
Use of nitric oxide donors for inducing neurogenesis
|
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
|
US7655423B2
(en)
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
|
US20010012851A1
(en)
|
1999-07-29 |
2001-08-09 |
Kristin M. Lundy |
Nitric oxide releasing oxindole prodrugs for anagesic, anti-inflammatory and disease-modifying use
|
|
US20020049157A1
(en)
|
1999-08-25 |
2002-04-25 |
Jiangping Wu |
Use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
|
|
US7279176B1
(en)
|
1999-09-02 |
2007-10-09 |
Rice University |
Nitric oxide-producing hydrogel materials
|
|
WO2001015738A2
(en)
|
1999-09-02 |
2001-03-08 |
Rice University |
Nitric oxide-producing hydrogel materials
|
|
US7052711B2
(en)
|
1999-09-02 |
2006-05-30 |
Rice University |
Nitric oxide-producing hydrogel materials
|
|
JP2003508604A
(ja)
*
|
1999-09-09 |
2003-03-04 |
クレアヴィス ゲゼルシャフト フュア テヒノロギー ウント イノヴェイション ミット ベシュレンクテル ハフツング |
抗菌性添加剤
|
|
US6737447B1
(en)
|
1999-10-08 |
2004-05-18 |
The University Of Akron |
Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
|
|
ATE323506T1
(de)
|
1999-12-20 |
2006-05-15 |
Majeste La Reine Du Chef Du Ca |
Methode und zusammensetzung zur behandlung und/oder prophylaxe von antibiotikum-resistenten- mikroorganismus infektionen
|
|
US6492405B2
(en)
|
1999-12-30 |
2002-12-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nitric oxide donors and pharmaceutical compositions containing them
|
|
WO2001053537A2
(en)
|
2000-01-24 |
2001-07-26 |
Dzgenes, Llc |
Nitric oxide synthase gene diagnostic polymorphisms
|
|
US6758214B2
(en)
|
2000-01-28 |
2004-07-06 |
Cyterra Corporation |
Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
|
|
US6699846B2
(en)
|
2000-03-17 |
2004-03-02 |
Corixa Corporation |
Mono- and disaccharides for the treatment of nitric oxide related disorders
|
|
MXPA02009236A
(es)
|
2000-03-20 |
2004-04-05 |
Novovascular Inc |
Matrices que contienen donadores de oxido nitrico y agentes reductores, y su uso.
|
|
US20010038832A1
(en)
|
2000-04-11 |
2001-11-08 |
Benjamin Bonavida |
Nitric oxide and analogues thereof effectuate sensitization of neoplasm and immunologically undesired tissues to cytotoxicity
|
|
US7678391B2
(en)
|
2000-04-26 |
2010-03-16 |
Queen's University At Kingston |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
US20050142217A1
(en)
|
2000-04-26 |
2005-06-30 |
Adams Michael A. |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
US6946484B2
(en)
|
2000-04-26 |
2005-09-20 |
Cellegy Pharmaceuticals, Inc. |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
US20010053772A1
(en)
|
2000-04-28 |
2001-12-20 |
Benjamin Bonavida |
Aza analogues of alkyl lysophospholipids exert immunomodulatory effects
|
|
US6270779B1
(en)
|
2000-05-10 |
2001-08-07 |
United States Of America |
Nitric oxide-releasing metallic medical devices
|
|
WO2001089519A1
(en)
|
2000-05-22 |
2001-11-29 |
Nitromed, Inc. |
Thromboxane inhibitors, compositions and methods of use related applications
|
|
US6623728B2
(en)
|
2000-06-30 |
2003-09-23 |
Unilever Home & Personal Care Usa Division Of Conopco, Inc. |
Cosmetic skin care compositions and containing gum mastic
|
|
US6475500B2
(en)
|
2000-07-10 |
2002-11-05 |
The Procter & Gamble Company |
Anhydrous cosmetic compositions
|
|
US6538033B2
(en)
|
2000-08-29 |
2003-03-25 |
Huntington Medical Research Institutes |
Nitric oxide donor compounds
|
|
GB0021317D0
(en)
|
2000-08-30 |
2000-10-18 |
Queen Mary & Westfield College |
Transdermal pharmaceutical delivery composition
|
|
JP4841066B2
(ja)
|
2000-09-01 |
2011-12-21 |
ライスユニバーシティ |
酸化窒素生成ヒドロゲル物質
|
|
GB0022084D0
(en)
|
2000-09-08 |
2000-10-25 |
Univ Aberdeen |
Treatment of multiply antibiotic-resistant organisms
|
|
US6410622B1
(en)
|
2000-09-11 |
2002-06-25 |
Gregory W. Endres |
Method of preventing fouling organisms in marine environments and polymer-bound nitric oxide/nitric oxide-releasing compositions usable therefor
|
|
CA2425489C
(en)
|
2000-10-16 |
2011-05-17 |
Duke University |
Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
|
|
EP1328262A2
(en)
|
2000-10-17 |
2003-07-23 |
Board of Regents, The University of Texas System |
A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
|
|
US6359182B1
(en)
|
2000-10-26 |
2002-03-19 |
Duke University |
C-nitroso compounds and use thereof
|
|
US7049308B2
(en)
|
2000-10-26 |
2006-05-23 |
Duke University |
C-nitroso compounds and use thereof
|
|
KR100383149B1
(ko)
|
2000-12-12 |
2003-05-12 |
한국생명공학연구원 |
디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도
|
|
DE10063937A1
(de)
|
2000-12-20 |
2002-07-18 |
Bayer Ag |
Verfahren zur Herstellung von Trimethylolverbindungen und Ameisensäure
|
|
US6780849B2
(en)
|
2000-12-21 |
2004-08-24 |
Scimed Life Systems, Inc. |
Lipid-based nitric oxide donors
|
|
US7329412B2
(en)
|
2000-12-22 |
2008-02-12 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial medical devices containing chlorhexidine free base and salt
|
|
US6432077B1
(en)
|
2000-12-26 |
2002-08-13 |
Sensormedics Corporation |
Device and method for treatment of surface infections with nitric oxide
|
|
US20040009238A1
(en)
|
2002-07-09 |
2004-01-15 |
Chris Miller |
Exogenenous nitric oxide gas (gNO) therapy in wound healing
|
|
US7122018B2
(en)
|
2000-12-26 |
2006-10-17 |
Sensormedics Corporation |
Device and method for treatment of wounds with nitric oxide
|
|
WO2002051902A1
(en)
*
|
2000-12-27 |
2002-07-04 |
World Properties Inc. |
Polyurethane foams and method of manafacture thereof
|
|
CA2433803A1
(en)
|
2001-01-16 |
2002-07-25 |
Mark E. Meyerhoff |
Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
|
|
US7128904B2
(en)
|
2001-01-16 |
2006-10-31 |
The Regents Of The University Of Michigan |
Material containing metal ion ligand complex producing nitric oxide in contact with blood
|
|
US7335383B2
(en)
|
2001-01-16 |
2008-02-26 |
The Regents Of The University Of Michigan |
Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
|
|
US6706274B2
(en)
|
2001-01-18 |
2004-03-16 |
Scimed Life Systems, Inc. |
Differential delivery of nitric oxide
|
|
ITMI20010426A1
(it)
|
2001-03-01 |
2002-09-01 |
Consiglio Nazionale Ricerche |
Donatori di ossido di azoto basati su centri metallici
|
|
US7012098B2
(en)
|
2001-03-23 |
2006-03-14 |
Pharmacia Corporation |
Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
|
|
US20020138051A1
(en)
|
2001-03-26 |
2002-09-26 |
Hole Douglas R. |
System and method for the prevention and treatment of animal wound infections using nitric oxide
|
|
US7122027B2
(en)
|
2001-05-25 |
2006-10-17 |
Medtronic, Inc. |
Implantable medical device with controllable gaseous agent release system
|
|
ES2180446B1
(es)
|
2001-07-02 |
2004-01-16 |
Esteve Labor Dr |
Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
|
|
WO2003006427A1
(en)
|
2001-07-12 |
2003-01-23 |
Johns Hopkins University |
Compounds that release nitric oxide at controlled rates upon photolysis
|
|
GB0119011D0
(en)
|
2001-08-03 |
2001-09-26 |
Univ Aberdeen |
Treatment of nail infections
|
|
US7432301B2
(en)
|
2001-08-20 |
2008-10-07 |
University Of Virginia Patent Foundation |
Use of S-nitrosothiol signaling to treat disordered control of breathing
|
|
US6841166B1
(en)
|
2001-08-21 |
2005-01-11 |
The Regents Of The University Of Michigan |
Nitric oxide-releasing polymers incorporating diazeniumdiolated silane derivatives
|
|
US7135189B2
(en)
|
2001-08-23 |
2006-11-14 |
Boston Scientific Scimed, Inc. |
Compositions and techniques for localized therapy
|
|
CA2833997C
(en)
|
2001-09-05 |
2017-09-26 |
Geno Llc |
Method and apparatus for nitric oxide generation
|
|
US6673338B1
(en)
|
2001-09-10 |
2004-01-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
|
|
WO2003026717A1
(en)
*
|
2001-09-26 |
2003-04-03 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Nitric oxide-releasing coated medical devices and method of preparing same
|
|
EP1300083A1
(en)
|
2001-10-04 |
2003-04-09 |
Societe Des Produits Nestle S.A. |
Milk-based snack
|
|
US6703046B2
(en)
|
2001-10-04 |
2004-03-09 |
Medtronic Ave Inc. |
Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
|
|
GB0125222D0
(en)
|
2001-10-19 |
2001-12-12 |
Barts & London Nhs Trust |
Composition for the treatment of microbial infections
|
|
US6627602B2
(en)
|
2001-11-13 |
2003-09-30 |
Duke University |
Preventing desensitization of receptors
|
|
US6472390B1
(en)
|
2001-11-13 |
2002-10-29 |
Duke University |
Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
|
|
US20040110691A1
(en)
|
2001-11-13 |
2004-06-10 |
Stamler Jonathan S. |
Thiol reactive agents as a therapeutic modality
|
|
JP2005511144A
(ja)
|
2001-12-03 |
2005-04-28 |
シー・アール・バード・インク |
微生物耐性医療用具、微生物耐性ポリマーコーティング及びその製造方法
|
|
AU2003235676A1
(en)
|
2002-01-15 |
2003-07-30 |
Trustees Of Dartmouth College |
Tricyclic-bis-enone derivatives and methods of use thereof
|
|
US6474508B1
(en)
|
2002-01-24 |
2002-11-05 |
Saint-Gobain Calmar Inc. |
Unit dose tube and cap assembly
|
|
EP1490045B1
(en)
|
2002-03-21 |
2013-03-13 |
University of Utah Research Foundation |
In vivo use of glutathionone s-transferase activated nitric oxide donors
|
|
US20030219854A1
(en)
|
2002-03-21 |
2003-11-27 |
Micrologix Biotech Inc. |
Methods for producing modified anti-infective peptides
|
|
US7765647B2
(en)
*
|
2002-04-04 |
2010-08-03 |
The University Of Akron |
Non-woven fiber assemblies
|
|
US20030203915A1
(en)
|
2002-04-05 |
2003-10-30 |
Xinqin Fang |
Nitric oxide donors, compositions and methods of use related applications
|
|
WO2003092763A1
(en)
|
2002-05-03 |
2003-11-13 |
Duke University |
Carbon nanotubules for storage of nitric oxide
|
|
WO2003095398A2
(en)
|
2002-05-07 |
2003-11-20 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
|
|
WO2004064723A2
(en)
|
2002-05-13 |
2004-08-05 |
Trustees Of Dartmouth College |
Inhibitors and methods of use thereof
|
|
US7070798B1
(en)
|
2002-06-21 |
2006-07-04 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
|
|
JP2005533812A
(ja)
|
2002-06-21 |
2005-11-10 |
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
一酸化窒素、ヘムオキシゲナーゼ−１、およびヘム分解生成物の薬学的使用
|
|
US6949530B2
(en)
|
2002-07-18 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
|
|
AU2003252033A1
(en)
|
2002-07-19 |
2004-02-09 |
University Of North Carolina At Chapel Hill |
Surface-localized release of an anti-biofouling agent via micropatterning
|
|
US7199154B2
(en)
|
2002-07-26 |
2007-04-03 |
Merck Frosst Company |
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
|
|
US7303575B2
(en)
*
|
2002-08-01 |
2007-12-04 |
Lumen Biomedical, Inc. |
Embolism protection devices
|
|
EP1545798A4
(en)
|
2002-08-02 |
2006-06-14 |
Us Gov Health & Human Serv |
NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R
|
|
US20040076582A1
(en)
|
2002-08-30 |
2004-04-22 |
Dimatteo Kristian |
Agent delivery particle
|
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
|
US6951902B2
(en)
|
2002-08-16 |
2005-10-04 |
Michigan Biotechnology Institute |
Two dimensional polymer that generates nitric oxide
|
|
US7674482B2
(en)
|
2002-08-27 |
2010-03-09 |
Targeted Medical Pharma Inc. |
Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
|
|
US20100210745A1
(en)
*
|
2002-09-09 |
2010-08-19 |
Reactive Surfaces, Ltd. |
Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
|
|
US20030039697A1
(en)
|
2002-09-12 |
2003-02-27 |
Yi-Ju Zhao |
Matrices containing nitric oxide donors and reducing agents and their use
|
|
CA2503063A1
(en)
|
2002-10-22 |
2004-05-06 |
Merck Frosst Canada & Co./Merck Frosst Canada & Cie |
Nitric oxide releasing selective cyclooxygenase-2 inhibitors
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US20070292359A1
(en)
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US20080206161A1
(en)
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
|
US20080031907A1
(en)
|
2002-10-25 |
2008-02-07 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
|
US20050271596A1
(en)
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US20080317679A1
(en)
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
|
US20070292461A1
(en)
|
2003-08-04 |
2007-12-20 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
GB0224986D0
(en)
*
|
2002-10-28 |
2002-12-04 |
Smith & Nephew |
Apparatus
|
|
AU2005239984B2
(en)
|
2002-10-29 |
2010-06-03 |
Brigham Young University |
Use of equol for treating skin diseases
|
|
WO2004046309A2
(en)
|
2002-11-18 |
2004-06-03 |
Phoenix Pharmacologics, Inc. |
Methods for inhibiting viral replication in vivo
|
|
AU2003293529A1
(en)
|
2002-12-16 |
2004-07-29 |
Nitromed, Inc. |
Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
|
|
WO2004064767A2
(en)
|
2003-01-23 |
2004-08-05 |
Kahn Nighat N |
Nitric oxide inducing agents
|
|
FR2850578B1
(fr)
|
2003-02-03 |
2006-07-28 |
Oreal |
Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
|
|
CA2517490A1
(en)
|
2003-03-05 |
2004-12-02 |
Merck Frosst Company |
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
|
|
CA2518506A1
(en)
|
2003-03-13 |
2004-11-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds, compositions and methods of use
|
|
SE0300971D0
(sv)
|
2003-04-03 |
2003-04-03 |
Aga Ab |
Nitric oxide in treatment of inflammation
|
|
US20040254419A1
(en)
|
2003-04-08 |
2004-12-16 |
Xingwu Wang |
Therapeutic assembly
|
|
US20050079132A1
(en)
|
2003-04-08 |
2005-04-14 |
Xingwu Wang |
Medical device with low magnetic susceptibility
|
|
US7972137B2
(en)
|
2003-06-30 |
2011-07-05 |
Rosen Gerald M |
Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
|
|
US7256921B2
(en)
|
2003-07-01 |
2007-08-14 |
Transitions Optical, Inc. |
Polarizing, photochromic devices and methods of making the same
|
|
AU2004253749B2
(en)
|
2003-07-03 |
2010-04-01 |
The University Court Of The University Of St Andrews |
Zeolites for delivery of nitric oxide
|
|
DE10330960B4
(de)
*
|
2003-07-08 |
2005-09-08 |
Stockhausen Gmbh |
Wirkstoffdotierte absorbierende Polymerteilchen , Zusammensetzung beinhaltend Polykondensatmatrix und absorbierendes Polymer zur Freisetzung einer Wundheilsubstanz
|
|
US7234079B2
(en)
|
2003-07-11 |
2007-06-19 |
Agency For Science, Technology & Research |
Method and system for enabling recovery of data stored in a computer network; a method and a system for recovering data stored in a computer network
|
|
US20050038473A1
(en)
|
2003-07-14 |
2005-02-17 |
Dov Tamarkin |
Device and method for the treatment of pilosebaceous disorders
|
|
US20050054714A1
(en)
|
2003-07-17 |
2005-03-10 |
Benito Munoz |
Nitric oxide releasing drugs for Alzheimer's disease
|
|
EP1648527A4
(en)
|
2003-07-25 |
2008-04-23 |
Univ Akron |
STABILIZATION AND IONIC RELEASE OF NITRIC OXIDE RELEASE
|
|
US20080069779A1
(en)
|
2003-08-04 |
2008-03-20 |
Foamix Ltd. |
Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
|
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US7314857B2
(en)
|
2003-08-25 |
2008-01-01 |
Kane Biotech Inc. |
Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
|
|
CA2536967A1
(en)
|
2003-08-28 |
2005-03-17 |
Nitromed, Inc. |
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
|
|
WO2005030147A2
(en)
|
2003-09-26 |
2005-04-07 |
Whitlock David R |
Methods of using ammonia oxidizing bacteria
|
|
CA2539973A1
(en)
|
2003-09-26 |
2005-04-07 |
Nitromed, Inc. |
Nitrosated glutamic acid compounds, compositions and methods of use
|
|
US7485324B2
(en)
|
2003-09-29 |
2009-02-03 |
Pulmonox Technologies Corporation |
Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
|
|
US20050074506A1
(en)
|
2003-10-02 |
2005-04-07 |
Brainsgate Ltd. |
Targeted release of nitric oxide in the CNS circulation for modulating the BBB and treating disorders
|
|
EP1691856A2
(en)
|
2003-10-14 |
2006-08-23 |
Cube Medical A/S |
Medical device with electrospun nanofibers
|
|
US20050171199A1
(en)
|
2003-10-17 |
2005-08-04 |
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
|
|
US20060286159A1
(en)
|
2003-10-17 |
2006-12-21 |
Calvert Murrell George A |
Treatment of persistent active tendinopathy using transdermal glyceryl trinitrate providing durability of effect
|
|
US20070059351A1
(en)
|
2003-10-17 |
2007-03-15 |
Murrell George A C |
Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
|
|
US20070053966A1
(en)
|
2003-10-17 |
2007-03-08 |
Robert Ang |
Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
|
|
US20060286158A1
(en)
|
2003-10-17 |
2006-12-21 |
Calvert Murrell George A |
Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
|
|
EP1694399B1
(en)
|
2003-12-15 |
2011-11-02 |
Nitricare HB |
Device for administering therapeutic agents
|
|
JP2007521118A
(ja)
|
2004-01-07 |
2007-08-02 |
ノクシライザー，インコーポレイテッド |
殺菌システムおよび装置
|
|
US8017074B2
(en)
|
2004-01-07 |
2011-09-13 |
Noxilizer, Inc. |
Sterilization system and device
|
|
AU2005207037A1
(en)
|
2004-01-22 |
2005-08-04 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
|
AU2005207039A1
(en)
|
2004-01-22 |
2005-08-04 |
Reneker, Darrell |
Polymer NO donor predrug nanofiber coating for medical devices and therapy
|
|
CA2554333A1
(en)
|
2004-01-27 |
2005-08-04 |
Merck Frosst Company |
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
|
|
AU2005206228A1
(en)
|
2004-01-27 |
2005-08-04 |
Merck Frosst Company |
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
|
|
US20050165452A1
(en)
|
2004-01-28 |
2005-07-28 |
Medtronic, Inc. |
Antithrombogenic medical device
|
|
EP1718603A4
(en)
|
2004-02-09 |
2009-09-23 |
Noxilizer Inc |
MOLECULES RELEASING NITROGEN MONOXIDE
|
|
US7569559B2
(en)
|
2004-02-09 |
2009-08-04 |
Noxilizer, Inc. |
Nitric oxide-releasing molecules
|
|
WO2005077962A2
(en)
|
2004-02-10 |
2005-08-25 |
Purdue Research Foundation |
Crowned dithiocarbamate metal complexes and methods for their use
|
|
CA2556967A1
(en)
|
2004-02-23 |
2005-09-09 |
Strategic Science & Technologies, Llc |
Topical delivery of a nitric oxide donor to improve body and skin appearance
|
|
WO2005107384A2
(en)
|
2004-03-31 |
2005-11-17 |
Nitromed, Inc. |
Methods for treating blood disorders with nitric oxide donor compounds
|
|
ES2429443T3
(es)
|
2004-04-19 |
2013-11-14 |
Strategic Science & Technologies, Llc |
Suministro transdérmico de sustancias beneficiosas efectuado mediante un entorno de fuerza iónica elevada
|
|
US8529548B2
(en)
*
|
2004-04-27 |
2013-09-10 |
Smith & Nephew Plc |
Wound treatment apparatus and method
|
|
WO2005115440A2
(en)
|
2004-04-29 |
2005-12-08 |
Kahn Nighat N |
Compositions and method for modulating insulin-activated nitric oxide synthase
|
|
US20060240065A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Yung-Ming Chen |
Compositions for medical devices containing agent combinations in controlled volumes
|
|
CA2565556A1
(en)
|
2004-05-03 |
2005-12-08 |
Neosil, Inc. |
Polycationic antimicrobial therapeutic
|
|
WO2005112974A2
(en)
|
2004-05-14 |
2005-12-01 |
William Marsh Rice University |
Peptide-modified polyurethane compositions and associated methods
|
|
WO2005112954A1
(en)
|
2004-05-14 |
2005-12-01 |
William Marsh Rice University |
Nitric oxide releasing compositions and associated methods
|
|
US7582623B2
(en)
|
2004-05-20 |
2009-09-01 |
The Regents Of The University Of California |
Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
|
|
EP1778215B1
(en)
|
2004-06-10 |
2009-12-09 |
Nippon Kayaku Kabushiki Kaisha |
Anticancer effect enhancer
|
|
US20060008529A1
(en)
|
2004-07-12 |
2006-01-12 |
Meyerhoff Mark E |
Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
|
|
US20060039950A1
(en)
|
2004-08-23 |
2006-02-23 |
Zhengrong Zhou |
Multi-functional biocompatible coatings for intravascular devices
|
|
CA2581939C
(en)
|
2004-09-27 |
2013-01-08 |
Joseph A. Hrabie |
Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
|
|
US20070154570A1
(en)
|
2004-09-29 |
2007-07-05 |
Miller Christopher C |
Use of nitric oxide in the treatment and disinfection of biofilms
|
|
US8067464B2
(en)
|
2004-10-04 |
2011-11-29 |
Nitromed, Inc. |
Compositions and methods using apocynin compounds and nitric oxide donors
|
|
FR2877004B1
(fr)
|
2004-10-21 |
2007-03-09 |
Oreal |
Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques.
|
|
US8388677B2
(en)
|
2004-10-29 |
2013-03-05 |
Boston Scientific Scimed, Inc. |
Anti-thrombogenic and anti-restenotic vascular medical devices
|
|
JP2008520578A
(ja)
|
2004-11-15 |
2008-06-19 |
ニトロメッド インコーポレーティッド |
複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
|
|
US20070166255A1
(en)
|
2004-11-22 |
2007-07-19 |
Gupta Shyam K |
Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
|
|
JP5188184B2
(ja)
|
2004-11-29 |
2013-04-24 |
ザ ユニバーシティ オブ アクロン |
局所的一酸化窒素供給装置およびその治療的使用方法
|
|
EP1681068A1
(en)
|
2004-12-16 |
2006-07-19 |
NOLabs AB |
Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide
|
|
WO2006064056A2
(en)
|
2004-12-16 |
2006-06-22 |
Nolabs Ab |
Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide
|
|
CA2592407A1
(en)
|
2004-12-24 |
2006-06-29 |
The University Of Queensland |
Methods of treating pain
|
|
SG175477A1
(en)
|
2005-01-31 |
2011-11-28 |
Mylan Lab Inc |
Hydroxylated nebivolol metabolites
|
|
WO2006084913A2
(en)
|
2005-02-11 |
2006-08-17 |
Nolabs Ab |
Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
|
|
EP1700611A1
(en)
|
2005-02-11 |
2006-09-13 |
NOLabs AB |
Device for treatment of disorders in the oral cavity, and manufacturing process for the same
|
|
EP1690558A1
(en)
|
2005-02-11 |
2006-08-16 |
NOLabs AB |
Device for treatment of diabetic disorders
|
|
EP1690557A1
(en)
|
2005-02-11 |
2006-08-16 |
NOLabs AB |
Device for treatment of rectal disorders, and manufacturing process for the same
|
|
WO2006084914A2
(en)
|
2005-02-11 |
2006-08-17 |
Nolabs Ab |
Device for gastric treatment and manufacturing process for the same
|
|
EP1707224A1
(en)
|
2005-02-11 |
2006-10-04 |
NOLabs AB |
Pharmaceutical mixture with nitric oxide booster, device for applying the mixture and manufacturing method therefor
|
|
DK1861130T3
(da)
|
2005-02-11 |
2009-01-26 |
Nolabs Ab |
Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis
|
|
EP1690532A1
(en)
|
2005-02-11 |
2006-08-16 |
NOLabs AB |
Device for gastric treatment and manufacturing process for the same
|
|
EP2119459A1
(en)
|
2005-02-11 |
2009-11-18 |
NOLabs AB |
Treatment of neuropathy involving nitric oxide
|
|
EP1757278A1
(en)
*
|
2005-08-23 |
2007-02-28 |
NOLabs AB |
Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer
|
|
WO2006084911A2
(en)
|
2005-02-11 |
2006-08-17 |
Nolabs Ab |
Improved device for application of medicaments, manufacturing method therefor, and method of treatment
|
|
JP2008530226A
(ja)
|
2005-02-16 |
2008-08-07 |
ニトロメッド インコーポレーティッド |
抗微生物化合物の有機酸化窒素供与体塩、組成物、および使用法
|
|
JP2008531579A
(ja)
|
2005-02-24 |
2008-08-14 |
ニトロメッド インコーポレーティッド |
酸化窒素増強利尿化合物、組成物および使用方法
|
|
WO2006096572A1
(en)
|
2005-03-04 |
2006-09-14 |
The University Of Akron |
Ethambutol based nitric oxide donors
|
|
EP1861093A2
(en)
|
2005-03-09 |
2007-12-05 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use
|
|
GB0505035D0
(en)
|
2005-03-11 |
2005-04-20 |
Insense Ltd |
Improvements relating to skin dressings
|
|
WO2006097348A1
(en)
|
2005-03-15 |
2006-09-21 |
L'oreal |
Use of agents such as nonpolymeric nitric oxide donors for making the lips full again and/or colouring the lips
|
|
JP5042209B2
(ja)
|
2005-03-24 |
2012-10-03 |
ノーラブズ エービー |
酸化窒素による美容治療、前記治療を実施する装置、及びその製造方法
|
|
EP1704879A1
(en)
|
2005-03-24 |
2006-09-27 |
NOLabs AB |
Intravascular, interstitial or intraorgan medical device comprising a nitric oxide eluting polymer
|
|
WO2006100155A1
(en)
|
2005-03-24 |
2006-09-28 |
Nolabs Ab |
Device for wound care, and manufacturing method thereof, involving the use of nitric oxide
|
|
WO2006100156A2
(en)
|
2005-03-24 |
2006-09-28 |
Nolabs Ab |
Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide
|
|
EP1704876A1
(en)
|
2005-03-24 |
2006-09-27 |
NOLabs AB |
Cosmetic treatment, device for performing said treatment and manufacturing method thereof
|
|
EP1704877A1
(en)
|
2005-03-24 |
2006-09-27 |
NOLabs AB |
A wound care device comprising a nitric oxide eluting polymer
|
|
AU2006313443A1
(en)
|
2005-05-09 |
2007-05-18 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
EP1885375A4
(en)
|
2005-05-16 |
2010-12-01 |
Univ Alberta |
NOVEL NSAIDS HAVING A DIAZENE-1-IUM-1,2-DIOLATE FRACTION NITRIC OXIDE DONOR
|
|
EP2151216B1
(en)
|
2005-05-17 |
2013-03-13 |
Syntach AG |
A device for treatment of disorders in the heart rhythm regulation system
|
|
WO2006127591A2
(en)
|
2005-05-23 |
2006-11-30 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
JP2008542208A
(ja)
|
2005-05-24 |
2008-11-27 |
エンバイロメンタル バイオテクノロジー シーアールシー ピーティーワイ リミテッド |
バイオフィルム発生を制御する方法及び組成物
|
|
JP5274248B2
(ja)
*
|
2005-05-27 |
2013-08-28 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
酸化窒素治療及び医生物的応用のための酸化窒素放出粒子
|
|
EP1728438A1
(en)
|
2005-06-01 |
2006-12-06 |
NOLabs AB |
Feedstuff
|
|
WO2006128743A1
(en)
|
2005-06-01 |
2006-12-07 |
Nolabs Ab |
Feedstuff
|
|
JP2008542327A
(ja)
|
2005-06-01 |
2008-11-27 |
ノーラブズ エービー |
一酸化窒素が関与する、処置および予備処置装置、ならびにその製造方法
|
|
EP1731176A1
(en)
*
|
2005-06-01 |
2006-12-13 |
NOLabs AB |
Pre-treatment device comprising nitric oxide
|
|
CA2820200C
(en)
|
2005-06-09 |
2015-08-18 |
Judith Esther Anderson |
Compositions and methods for enhancing nitric oxide delivery
|
|
US20080241208A1
(en)
|
2005-06-30 |
2008-10-02 |
Charles Shanley |
Methods, Compositions and Devices For Promoting Anglogenesis
|
|
EP1896091B1
(en)
|
2005-06-30 |
2011-06-22 |
Accord Biomaterials, Inc. |
Nitric oxide coatings for medical devices
|
|
AU2006265707B2
(en)
|
2005-07-01 |
2012-06-14 |
Kane Biotech Inc. |
Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
|
|
US20080139450A1
(en)
|
2005-07-01 |
2008-06-12 |
Srinivasa Madhyastha |
Antimicrobial Compositions and Uses Thereof
|
|
US20080152596A1
(en)
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
BRPI0503201B8
(pt)
|
2005-07-28 |
2021-05-25 |
Sci Tech Produtos Medicos Ltda |
stents revestidos com blendas poliméricas hidrofílicas, eluidoras de óxido nítrico e s-nitrosotióis
|
|
EP1915157A4
(en)
|
2005-08-02 |
2010-09-01 |
Nicox Sa |
NICKEL OXYGENIZING ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND USE PROCESSES
|
|
US8021679B2
(en)
|
2005-08-25 |
2011-09-20 |
Medtronic Vascular, Inc |
Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
|
|
RU2400102C2
(ru)
|
2005-08-26 |
2010-09-27 |
Нестек С.А. |
Композиция для лечения, замедления или предотвращения у животного слабоумия, старения мозга, когнитивного нарушения, инсульта или болезни альцгеймера и ее применение (варианты)
|
|
US20070048344A1
(en)
|
2005-08-31 |
2007-03-01 |
Ali Yahiaoui |
Antimicrobial composition
|
|
US20070053952A1
(en)
|
2005-09-07 |
2007-03-08 |
Medtronic Vascular, Inc. |
Nitric oxide-releasing polymers derived from modified polymers
|
|
EP1764119A1
(en)
|
2005-09-09 |
2007-03-21 |
NOLabs AB |
Implants with improved osteointegration
|
|
US20090010989A1
(en)
|
2005-09-12 |
2009-01-08 |
N0Labs Ab |
Coating For Implants and Implants With Improved Osteointegration, and Manufacturing Method
|
|
WO2007042153A1
(en)
|
2005-10-11 |
2007-04-19 |
Bayer Consumer Care Ag |
Mixture of iron and copper salts masking mettalic taste
|
|
US20070088345A1
(en)
|
2005-10-13 |
2007-04-19 |
Ust Inc. |
Applications of HIFU and chemotherapy
|
|
US7531164B2
(en)
|
2005-10-21 |
2009-05-12 |
Duke University |
Preventing bacterial or viral infectivity and composition containing infection preventing additive
|
|
WO2007053578A2
(en)
|
2005-10-31 |
2007-05-10 |
Amulet Pharmaceuticals, Inc. |
Multi-phasic nitric oxide and drug co-eluting stent coatings
|
|
AU2006309212B2
(en)
|
2005-10-31 |
2011-09-15 |
Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services |
Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
|
|
EP1790335A1
(en)
|
2005-11-14 |
2007-05-30 |
NOLabs AB |
Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract
|
|
EP1954685A4
(en)
|
2005-11-16 |
2009-11-11 |
Nitromed Inc |
FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
|
|
US20070116785A1
(en)
|
2005-11-18 |
2007-05-24 |
Miller Christopher C |
Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
|
|
CN101378792A
(zh)
|
2005-12-02 |
2009-03-04 |
密执安大学评议会 |
聚合物组合物、涂层和装置及其制备和使用方法
|
|
US20070129690A1
(en)
|
2005-12-02 |
2007-06-07 |
Joel Rosenblatt |
Catheter with polymeric coating
|
|
AU2006322035A1
(en)
|
2005-12-06 |
2007-06-14 |
Amulet Pharmaceuticals, Inc. |
Nitric oxide-releasing polymers
|
|
US20070243262A1
(en)
|
2005-12-21 |
2007-10-18 |
Hurley Kevin P |
Stable S-nitrosothiol formulations
|
|
WO2007084533A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of Akron |
Debridement method using topical nitric oxide donor devices and compositions
|
|
EP1979487A4
(en)
|
2006-01-26 |
2010-05-05 |
Bebaas Inc |
COBALAMINE COMPOSITIONS FOR THE TREATMENT OF CANCER
|
|
EP1983975B1
(en)
|
2006-02-03 |
2015-07-29 |
Giulio Cossu |
Method of treatment for muscular dystrophy
|
|
EP1978947B1
(en)
|
2006-02-03 |
2014-08-13 |
Nicox S.A. |
Nitrooxyderivatives for use in the treatment of muscular dystrophies
|
|
US20070202155A1
(en)
|
2006-02-03 |
2007-08-30 |
Cure Therapeutics, Inc. |
Low dose no donor-containing transdermal patch
|
|
US20070203242A1
(en)
|
2006-02-27 |
2007-08-30 |
Calwood Nutritionals, Inc. |
Method for treating gastric reflux
|
|
US20070219208A1
(en)
|
2006-02-27 |
2007-09-20 |
Balaraman Kalyanaraman |
Methods for Treating Cancer
|
|
US7645748B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol phosphorylnitroderivatives and use thereof
|
|
US7645749B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol nitroderivatives and use thereof
|
|
EP2010486A2
(en)
|
2006-04-24 |
2009-01-07 |
The Government Of The United States Of America As Representative National Institutes of Health |
Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods
|
|
US8241619B2
(en)
|
2006-05-15 |
2012-08-14 |
Medtronic Vascular, Inc. |
Hindered amine nitric oxide donating polymers for coating medical devices
|
|
US20080171351A1
(en)
|
2006-05-22 |
2008-07-17 |
University Of Notre Dame Du Lac |
Probes for anionic cell surface detection
|
|
WO2008038140A2
(en)
|
2006-06-07 |
2008-04-03 |
Foamix Ltd. |
Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
|
|
EP2040554A4
(en)
|
2006-06-16 |
2010-05-26 |
Alltech Inc |
REDUCTION OF ANTIBIOTIC RESISTANCE IN BACTERIA
|
|
US8333997B2
(en)
|
2006-06-21 |
2012-12-18 |
Albert Einstein College Of Medicine Of Yeshiva University |
Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
|
|
WO2008110872A2
(en)
|
2006-06-23 |
2008-09-18 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
|
DK2494959T3
(da)
|
2006-07-05 |
2015-02-23 |
Foamix Pharmaceuticals Ltd |
Skumbart dicarboxylsyrebærestof og farmaceutiske sammensætninger deraf
|
|
EP2051935B1
(en)
|
2006-07-26 |
2016-09-07 |
STMicroelectronics Srl |
Use of nitroaniline derivatives for the production of nitric oxide
|
|
US20080025972A1
(en)
|
2006-07-26 |
2008-01-31 |
Duke University |
Treating sex steriod responsive disorders
|
|
CN101563113B
(zh)
*
|
2006-08-03 |
2013-10-23 |
利兰斯坦福青年大学托管委员会 |
用于治疗或预防伤疤和/或瘢痕的设备和绷带及其方法和套件
|
|
GB0616350D0
(en)
|
2006-08-17 |
2006-09-27 |
Univ St Andrews |
Adsorption and release of nitric oxide in metal organic frameworks
|
|
EP1895012A1
(en)
|
2006-08-30 |
2008-03-05 |
Universitätsklinikum Freiburg |
Method for inducing tumor apoptosis by increasing nitric oxide levels
|
|
JP2010512805A
(ja)
*
|
2006-08-30 |
2010-04-30 |
サウス−イースタン メディカル テクノロジーズ |
大気圧から変更された圧力を使用して創傷を治療するための方法、組成物及び装置
|
|
KR20090064440A
(ko)
|
2006-09-08 |
2009-06-18 |
포믹스 리미티드 |
착색된 또는 착색 가능한 발포성 조성물 및 발포체
|
|
GB0618711D0
(en)
|
2006-09-22 |
2006-11-01 |
Univ Exeter |
Agricultural treatment
|
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
AU2007356328A1
(en)
|
2006-11-14 |
2009-01-15 |
Tal Berman |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
|
US10322155B2
(en)
|
2006-11-15 |
2019-06-18 |
Arthritis Relief Plus Ltd. |
Topical formulation and uses thereof
|
|
GB0623531D0
(en)
|
2006-11-25 |
2007-01-03 |
Univ St Andrews |
Nitric oxide storage and production
|
|
EP2097065A2
(en)
|
2006-11-29 |
2009-09-09 |
Foamix Ltd. |
Foamable waterless compositions with modulating agents
|
|
US20090112197A1
(en)
|
2007-10-30 |
2009-04-30 |
Searete Llc |
Devices configured to facilitate release of nitric oxide
|
|
US7862598B2
(en)
|
2007-10-30 |
2011-01-04 |
The Invention Science Fund I, Llc |
Devices and systems that deliver nitric oxide
|
|
US20090110933A1
(en)
|
2007-10-30 |
2009-04-30 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and devices related to nitric oxide releasing materials
|
|
US8642093B2
(en)
|
2007-10-30 |
2014-02-04 |
The Invention Science Fund I, Llc |
Methods and systems for use of photolyzable nitric oxide donors
|
|
US8221690B2
(en)
|
2007-10-30 |
2012-07-17 |
The Invention Science Fund I, Llc |
Systems and devices that utilize photolyzable nitric oxide donors
|
|
US20080292560A1
(en)
|
2007-01-12 |
2008-11-27 |
Dov Tamarkin |
Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
|
|
US20080175881A1
(en)
|
2007-01-18 |
2008-07-24 |
Boston Scientific Scimed, Inc. |
Blood-contacting medical devices for the release of nitric oxide and anti-restenotic agents
|
|
EP2114427B1
(en)
|
2007-01-30 |
2014-06-25 |
New York University |
Peptides for treatment of conditions associated with nitric oxide
|
|
ES2604562T3
(es)
|
2007-02-05 |
2017-03-07 |
Nicox Science Ireland |
Compuestos donantes de óxido nítrico
|
|
US20080193385A1
(en)
|
2007-02-08 |
2008-08-14 |
Todd Maibach |
Compositions and methods for treating neuropathy
|
|
US20080193566A1
(en)
|
2007-02-09 |
2008-08-14 |
Miller Christopher C |
Use of high dose concentrations of gaseous nitric oxide
|
|
WO2008100591A2
(en)
|
2007-02-14 |
2008-08-21 |
The General Hospital Corporation |
Modulation of nitric oxide signaling to normalize tumor vasculature
|
|
US7811600B2
(en)
|
2007-03-08 |
2010-10-12 |
Medtronic Vascular, Inc. |
Nitric oxide donating medical devices and methods of making same
|
|
WO2008116497A1
(en)
|
2007-03-27 |
2008-10-02 |
Nolabs Ab |
Topical termal delivery device for nitric oxide delivery
|
|
US8598368B2
(en)
|
2007-04-20 |
2013-12-03 |
Duke University |
Stable neutral nitric oxide source
|
|
WO2008150505A1
(en)
|
2007-06-01 |
2008-12-11 |
Amulet Pharmaceuticals, Inc. |
Compounds, polymers and methods for treating gastrointestinal dysfunction
|
|
JP2010530001A
(ja)
|
2007-06-15 |
2010-09-02 |
イカリア， インコーポレイテッド |
硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用
|
|
US8273828B2
(en)
|
2007-07-24 |
2012-09-25 |
Medtronic Vascular, Inc. |
Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation
|
|
EP2170157B1
(en)
|
2007-07-26 |
2016-09-07 |
Duke University |
Measuring amount of bound and combined nitric oxide in blood
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
GB0715554D0
(en)
|
2007-08-09 |
2007-09-19 |
Insense Ltd |
Improvements relating to skin dressings
|
|
GB0715556D0
(en)
|
2007-08-09 |
2007-09-19 |
Insense Ltd |
Improvements relating to skin dressings
|
|
CA2599082A1
(en)
|
2007-08-27 |
2009-02-27 |
Ping I. Lee |
Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
|
|
WO2009071990A2
(en)
|
2007-08-31 |
2009-06-11 |
Topigen Pharmaceuticals Inc. |
No-donating cordicosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties
|
|
WO2009056991A2
(en)
|
2007-09-04 |
2009-05-07 |
Foamix Ltd. |
Device for delivery of a foamable composition
|
|
US8043246B2
(en)
|
2007-09-21 |
2011-10-25 |
Enox Biopharma, Inc. |
Antimicrobial gas-releasing ear drainage tubes
|
|
WO2009049208A1
(en)
*
|
2007-10-12 |
2009-04-16 |
The University Of North Carolina At Chapel Hill |
Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
|
|
US9453115B2
(en)
|
2007-10-12 |
2016-09-27 |
Honeywell International Inc. |
Stabilization of polyurethane foam polyol premixes containing halogenated olefin blowing agents
|
|
US8877508B2
(en)
|
2007-10-30 |
2014-11-04 |
The Invention Science Fund I, Llc |
Devices and systems that deliver nitric oxide
|
|
US20090112055A1
(en)
|
2007-10-30 |
2009-04-30 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Sleeves configured to facilitate release of nitric oxide
|
|
US7897399B2
(en)
|
2007-10-30 |
2011-03-01 |
The Invention Science Fund I, Llc |
Nitric oxide sensors and systems
|
|
US8349262B2
(en)
|
2007-10-30 |
2013-01-08 |
The Invention Science Fund I, Llc |
Nitric oxide permeable housings
|
|
US20090112193A1
(en)
|
2007-10-30 |
2009-04-30 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and devices that utilize photolyzable nitric oxide donors
|
|
WO2009064861A2
(en)
|
2007-11-13 |
2009-05-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitric oxide-releasing diazeniumdiolated polymers, compositions, medical devices, and uses thereof
|
|
US20090130029A1
(en)
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
|
US9439857B2
(en)
|
2007-11-30 |
2016-09-13 |
Foamix Pharmaceuticals Ltd. |
Foam containing benzoyl peroxide
|
|
WO2009073643A2
(en)
|
2007-12-03 |
2009-06-11 |
Cleveland State University |
Nitric oxide release coatings incorporating nitric oxide synthase enzyme
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
BRPI0705396B1
(pt)
|
2007-12-12 |
2021-10-05 |
Universidade Estadual De Campinas - Unicamp |
Compostos derivados ftalimídicos
|
|
IE20070934A1
(en)
|
2007-12-21 |
2009-06-24 |
Trinity College Dublin |
Efficient aspirin prodrugs
|
|
JP2011507968A
(ja)
|
2007-12-27 |
2011-03-10 |
エイヤーズ ファーマシューティカルズ、インク． |
エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用
|
|
US20090177133A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Kristine Kieswetter |
Reduced pressure dressing coated with biomolecules
|
|
BRPI0822238B8
(pt)
|
2008-01-04 |
2021-05-25 |
Nestec Sa |
composições compreendendo ácidos graxos insaturados e compostos liberadores de óxido nítrico
|
|
CA2711703A1
(en)
|
2008-01-08 |
2009-07-16 |
Foamix Ltd. |
Sensation modifying topical composition foam
|
|
US8720436B2
(en)
|
2008-01-31 |
2014-05-13 |
Genosys, Inc. |
Nitric oxide gel apparatus and method
|
|
PL2240170T3
(pl)
|
2008-01-31 |
2019-11-29 |
Univ Vanderbilt |
Sposoby i kompozycje do leczenia wieńcowego i tętniczego tętniakowego krwotoku podpajęczynówkowego
|
|
WO2009098113A1
(en)
|
2008-02-07 |
2009-08-13 |
Nicox S.A. |
Nitric oxide donor compounds
|
|
US20090222088A1
(en)
|
2008-02-29 |
2009-09-03 |
Medtronic Vascular, Inc. |
Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
|
|
US20090232868A1
(en)
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Nitric Oxide Releasing Polymer Composition
|
|
US20090232863A1
(en)
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
|
|
WO2009124379A1
(en)
|
2008-04-09 |
2009-10-15 |
Enox Biopharma, Inc. |
Biofilm-inhibiting catheters and tubings
|
|
BRPI0907260A2
(pt)
|
2008-04-21 |
2015-07-14 |
3M Innovative Properties Co |
"métodos, dispositivos e composições que liberam óxido nítrico"
|
|
US20120141384A1
(en)
|
2008-05-06 |
2012-06-07 |
Dov Tamarkin |
Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
|
|
JP2011525116A
(ja)
|
2008-06-24 |
2011-09-15 |
マイクロファーマ・リミテッド |
一酸化窒素デバイス、ならびに創傷の治癒、皮膚障害および微生物感染症の治療の方法
|
|
US8852640B2
(en)
|
2008-07-03 |
2014-10-07 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Micelles for delivery of nitric oxide
|
|
US20100040703A1
(en)
|
2008-08-13 |
2010-02-18 |
Chris Miller |
Use of nitric oxide
|
|
EP2331606B1
(en)
|
2008-09-19 |
2016-11-02 |
Northwestern University |
Biodegradable nitric oxide generating polymers and related biomedical devices
|
|
US7807716B2
(en)
|
2008-09-24 |
2010-10-05 |
Oral Delivery Technology Ltd. |
Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
|
|
US20100086530A1
(en)
|
2008-10-06 |
2010-04-08 |
Martinov Norman P |
Cancer-tumor necrosis by artery nutrient-oxygen blocking
|
|
EP2349442B1
(en)
|
2008-10-15 |
2023-07-26 |
University of Tennessee Research Foundation |
Method and device for detection of bioavailable drug concentration in a fluid sample
|
|
US20100098733A1
(en)
*
|
2008-10-16 |
2010-04-22 |
Novan, Inc. |
Nitric oxide releasing particles for oral care applications
|
|
US20100099766A1
(en)
|
2008-10-16 |
2010-04-22 |
Novartis Ag |
Topical NSAID compositions having sensate component
|
|
WO2010048724A1
(en)
|
2008-10-30 |
2010-05-06 |
Chris Miller |
Nitric oxide-releasing dressings
|
|
WO2010051378A1
(en)
|
2008-10-31 |
2010-05-06 |
Noxilizer, Inc. |
Powder sterilization
|
|
US8158187B2
(en)
|
2008-12-19 |
2012-04-17 |
Medtronic Vascular, Inc. |
Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices
|
|
US20100197702A1
(en)
|
2009-02-04 |
2010-08-05 |
Hellberg Mark R |
Ophthalmic composition with nitric oxide donor compound and method of forming and using same
|
|
US8062653B2
(en)
|
2009-02-18 |
2011-11-22 |
Bezwada Biomedical, Llc |
Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
|
|
WO2010096320A2
(en)
|
2009-02-18 |
2010-08-26 |
Bezwada Biomedical, Llc |
Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
|
|
US9278113B2
(en)
|
2009-03-30 |
2016-03-08 |
The Board Of Regents, The University Of Texas System |
Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof
|
|
US8236341B2
(en)
|
2009-04-02 |
2012-08-07 |
Medtronic Vascular, Inc. |
Poly(tetrafluoroethylene) polymer with nitric oxide donating surface
|
|
US8801801B2
(en)
*
|
2009-04-03 |
2014-08-12 |
Biomerix Corporation |
At least partially resorbable reticulated elastomeric matrix elements and methods of making same
|
|
US8709465B2
(en)
|
2009-04-13 |
2014-04-29 |
Medtronic Vascular, Inc. |
Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
|
|
CA2763804C
(en)
|
2009-06-22 |
2018-02-06 |
Geno Llc |
Nitric oxide therapies
|
|
US20110059189A1
(en)
|
2009-09-08 |
2011-03-10 |
Cisne Enterprises Inc. |
Method and composition for treating cancer, effecting apoptosis and treating retroviral infections
|
|
EP2488591A1
(en)
|
2009-10-13 |
2012-08-22 |
Novan, Inc. |
Nitric oxide-releasing coatings
|